Definition and pathophysiology
Post-infarction mechanical complications are structural disruptions of acutely infarcted myocardium occurring most often during the first days after ST-elevation myocardial infarction (STEMI). The principal lesions are:
Ventricular septal rupture (VSR), producing an acute left-to-right shunt.
Ventricular free-wall rupture, producing haemopericardium and cardiac tamponade.
Papillary muscle rupture, producing acute severe mitral regurgitation (MR).
These complications result from transmural myocardial necrosis and subsequent tissue disruption. Infarct expansion and, in some cases, a dissecting haematoma may precede rupture. The tear commonly develops at the interface between infarcted and viable myocardium.
The incidence has fallen substantially with contemporary reperfusion, particularly primary percutaneous coronary intervention (PCI). In a large epidemiological analysis, mechanical complications occurred in approximately 0.27% of STEMI cases and 0.06% of non-ST-elevation myocardial infarction cases. Despite their rarity, they remain immediately life-threatening; reported in-hospital mortality was 42.4% for STEMI-associated mechanical complications and 18% for those associated with NSTEMI.
The timing of VSR, free-wall rupture, and papillary muscle rupture is characteristically bimodal. Events may occur within the first 24 hours or around days 3–5, although the reported range extends from 1 to 14 days after infarction. VSR may also occur as late as 2 weeks after infarction.
Predisposing features
Risk features vary by lesion but include:
Older age.
Female sex.
Hypertension.
Absence of an adequate collateral circulation.
A first or anterior infarction.
Single-vessel disease without collateral support.
Chronic kidney disease, particularly in relation to VSR.
Large infarction, especially for septal or free-wall rupture.
Free-wall rupture is more common after fibrinolytic therapy than after PCI in the reported clinical profile, whereas primary PCI appears to reduce its risk. VSR incidence has decreased from approximately 1–2% without reperfusion to about 0.2% in the reperfusion era.
Clinical presentation and symptoms
A new episode of hypotension, recurrent chest pain, pulmonary congestion, a new cardiac murmur, or jugular venous distension in the days after MI should prompt immediate consideration of a mechanical complication. Clinical deterioration may be abrupt or progressive, and cardiogenic shock may develop rapidly.
Ventricular septal rupture
VSR typically causes:
Recurrent chest pain.
Dyspnoea.
Hypotension.
Rapid development of biventricular failure.
Pulmonary oedema.
Cardiogenic shock.
The shunt may initially be tolerated, but the defect can enlarge and cause rapid haemodynamic deterioration. Inferior infarction is associated with basal septal perforation and a worse prognosis than the typically apical defect associated with anterior infarction.
Ventricular free-wall rupture
Free-wall rupture may be catastrophic or subacute.
In the catastrophic form, an acute tear causes haemopericardium, tamponade, and sudden:
Loss of pulse.
Loss of blood pressure.
Loss of consciousness.
Electromechanical dissociation or pulseless electrical activity despite ongoing sinus rhythm on the ECG.
Subacute rupture may be suggested by:
Nausea.
Hypotension.
Pericardial or pleuritic discomfort.
Syncope.
Restlessness.
Jugular venous distension.
Pulsus paradoxus.
The pericardium may temporarily seal the rupture, producing subacute tamponade and cardiogenic shock rather than immediate death.
Papillary muscle rupture
Papillary muscle rupture causes abrupt severe MR. Its typical presentation is:
Sudden severe dyspnoea.
Acute pulmonary oedema.
Hypotension.
Progressive heart failure.
Cardiogenic shock.
Complete transection of a papillary muscle may cause immediately overwhelming MR. Partial rupture, often involving the tip or head of the muscle, more commonly produces severe but initially survivable MR.
The posteromedial papillary muscle is affected more often than the anterolateral muscle because it has a singular blood supply. Posteromedial rupture is usually associated with inferior infarction, whereas anterolateral rupture follows anterolateral infarction. In approximately half of cases, papillary muscle rupture occurs despite a relatively small infarct and may be associated with only modest coronary disease.
Evaluation and physical examination
Any patient with recent STEMI and sudden or progressive haemodynamic deterioration requires urgent assessment for mechanical disruption. Immediate echocardiography is indicated when there is:
Sudden hypotension.
Recurrent chest pain.
A new murmur.
Pulmonary congestion or oedema.
Jugular venous distension.
Unexplained cardiogenic shock.
Electromechanical dissociation or pulseless electrical activity.
Examination should focus on the circulation, pulmonary congestion, signs of right- and left-sided failure, tamponade, and new murmurs. A murmur may be deceptively soft or absent in acute severe MR because rapid pressure equalisation limits the audible regurgitant gradient. Similarly, a murmur may diminish or disappear as systemic arterial pressure falls.
Physical findings by lesion
| Lesion | Characteristic examination findings |
|---|---|
| VSR | Harsh, loud holosystolic murmur, usually best heard at the lower left sternal border; thrill; accentuated S2; S3; pulmonary oedema; right- and left-ventricular failure; cardiogenic shock |
| Free-wall rupture | Jugular venous distension, pulsus paradoxus, electromechanical dissociation, hypotension, tamponade, cardiogenic shock |
| Papillary muscle rupture | Severe pulmonary oedema, hypotension, cardiogenic shock; murmur may be soft, variable, or absent; a thrill is generally absent |
The presence of a new holosystolic murmur strongly supports VSR or acute MR, but the absence of a prominent murmur does not exclude either lesion.
Diagnostics
Echocardiography
Echocardiography is the principal immediate diagnostic investigation. It should be performed without delay when a mechanical complication is suspected.
VSR
Echocardiography may show:
The septal defect itself.
Turbulent systolic flow across the interventricular septum on colour-flow Doppler.
A left-to-right shunt.
Right-ventricular volume overload.
The defect may be direct or irregular and serpiginous, with a length ranging from one to several centimetres.
Free-wall rupture
Possible echocardiographic findings include:
Pericardial effusion, although an effusion greater than 5 mm is not consistently visualised.
Layered, high-acoustic echoes within the pericardium representing blood clot.
Direct visualisation of the myocardial tear.
Echocardiographic features of tamponade.
A negative or equivocal echocardiogram does not exclude rupture, particularly when the pericardial blood is loculated or has rapidly clotted.
Papillary muscle rupture
Echocardiography may demonstrate:
A hypercontractile left ventricle.
A ruptured papillary muscle or chordae tendineae.
A flail mitral leaflet.
Severe MR on colour-flow Doppler.
Transthoracic echocardiography may be inadequate when the regurgitant jet is narrow and eccentric or when rapid pressure equalisation limits the apparent jet. If clinical suspicion remains high, transoesophageal echocardiography should be used because it provides greater diagnostic accuracy.
Colour-flow Doppler is particularly useful in distinguishing acute MR from VSR in the setting of STEMI.
Right-heart catheterisation
Pulmonary artery catheterisation may help define the haemodynamic lesion when the diagnosis or severity remains uncertain.
VSR
Findings include:
An increase in oxygen saturation between the right atrium and right ventricle, reflecting the left-to-right shunt.
Large v waves.
Papillary muscle rupture
Findings include:
No oxygen-saturation step-up between the right atrium and right ventricle.
Large v waves.
Very high pulmonary capillary wedge pressure.
Free-wall rupture
Ventriculography is insensitive. Classical tamponade findings may not always be present, although equalisation of diastolic pressures among the cardiac chambers can occur.
Invasive monitoring is warranted when a major mechanical complication has been recognised, unless immediate definitive repair is undertaken.
Electrocardiography
The source material describes ongoing sinus rhythm on the ECG in catastrophic free-wall rupture despite loss of pulse and blood pressure, reflecting pulseless electrical activity from tamponade. No additional ECG criteria for differentiating VSR, free-wall rupture, or papillary muscle rupture are specified.
Biomarkers and laboratory findings
The source material does not provide specific biomarker or laboratory patterns for post-infarction VSR, free-wall rupture, or papillary muscle rupture. Diagnosis is primarily clinical, echocardiographic, and haemodynamic.
Treatment and management
Post-infarction mechanical complications require immediate involvement of a multidisciplinary Heart Team, with parallel stabilisation, definitive anatomical assessment, and planning for repair. Management should incorporate the patient’s goals of care, particularly where the likelihood of futility is high.
Surgery is generally the treatment of choice. Delay may permit progressive shock, infection, acute lung injury, infarct extension, or renal failure. Operative survival is favoured by:
Early surgery.
A short duration of shock.
Mild right- and left-ventricular impairment.
Identification of a surgically correctable lesion.
Initial haemodynamic stabilisation
For acute MR and VSR, vasodilator therapy—usually nitroglycerin or nitroprusside—should be started as soon as possible when systolic blood pressure is not below 90 mm Hg. Vasodilators reduce afterload and may improve forward cardiac output and the haemodynamic consequences of the shunt or regurgitation.
Inotropic agents may be used to support cardiac output. Pharmacological therapy is intended to stabilise the patient sufficiently to permit diagnostic studies and definitive repair.
If medications are not tolerated or do not restore haemodynamic stability, temporary mechanical circulatory support is reasonable as a bridge to repair. Patients with ACS-related mechanical complications should be considered for intra-aortic balloon counterpulsation while awaiting surgery. More active mechanical circulatory support may be appropriate for stabilisation in selected patients, although evidence for routine use remains limited.
Ventricular septal rupture
VSR generally requires urgent definitive closure because the defect may expand even when the patient is initially stable.
Management options include:
Surgical closure, most commonly the definitive treatment.
Temporary pharmacological afterload reduction.
Intra-aortic balloon counterpulsation as a bridge.
Other temporary mechanical circulatory support when required.
Transcatheter closure in selected patients.
Surgical repair is performed through the infarcted ventricular wall, with closure of the septal defect using a prosthetic patch and repair of the ventricular incision with a second patch.
Current American recommendations favour immediate surgical closure irrespective of haemodynamic status. European practice is more selective and relies on Heart Team assessment. Decisions should incorporate the patient’s anatomy, haemodynamic course, operative risk, ventricular function, and goals of care.
Transcatheter closure may be considered:
As a bridge to later definitive surgery after additional infarct healing.
In patients who are not candidates for early surgery.
In patients considered inoperable when the anatomy is suitable.
Initial device closure is almost always incomplete, and the device requires time for thrombosis and endothelialisation. Accordingly, surgery remains the preferred treatment for most patients with haemodynamically significant VSR.
Free-wall rupture
Free-wall rupture requires prompt surgical repair. Catastrophic rupture with tamponade and pulseless electrical activity is an extreme emergency. Subacute rupture may permit brief stabilisation, but definitive repair remains necessary because the clinical course can rapidly deteriorate.
The high mortality associated with free-wall rupture is driven by the severity of tamponade, shock, and the underlying infarct. Prompt recognition and surgical intervention are the principal determinants of survival.
Papillary muscle rupture
Acute severe MR from papillary muscle rupture generally requires urgent operative treatment. Complete rupture usually necessitates mitral valve replacement.
The operative approach may include:
Debridement of the damaged papillary and leaflet tissue.
Preservation of viable commissural or leaflet segments where possible.
Mitral valve replacement with retention of partial annular–papillary continuity.
Selective mitral valve repair in anatomically suitable cases, including transfer of a papillary head to an intact segment.
Replacement is usually required after complete papillary muscle rupture. The choice between repair and replacement depends on the extent of disruption and the ability to preserve effective valve function and ventricular geometry.
Timing of surgery
In patients with a surgically correctable lesion who require pharmacological or mechanical support, surgery should generally not be delayed. Delayed intervention is associated with the risk of progressive shock and multiorgan complications.
If the patient remains haemodynamically stable, surgery may sometimes be deferred for approximately 2–4 weeks to permit partial infarct healing. Such postponement requires careful reassessment of:
Haemodynamic stability.
The anatomy and size of the defect.
Right- and left-ventricular function.
The trajectory of heart failure.
The likelihood of further tissue disruption.
The patient’s values and treatment goals.
These decisions require multidisciplinary Heart Team management rather than reliance on a fixed interval.
Guideline recommendations
The source material supports the following recommendations:
Immediate echocardiographic assessment is indicated when a post-MI mechanical complication is suspected.
Major mechanical complications merit invasive monitoring unless immediate definitive repair is undertaken.
Surgery is the treatment of choice for ACS-related mechanical complications.
Intra-aortic balloon counterpulsation should be considered while patients with ACS-related mechanical complications await surgery.
VSR requires prompt closure because the defect may enlarge and haemodynamic deterioration may occur even in initially stable patients.
American guidance recommends immediate surgical VSR closure irrespective of haemodynamic status; European guidance recommends a more selective Heart Team approach.
Temporary mechanical circulatory support is reasonable when pharmacological treatment fails or is not tolerated.
Transcatheter closure is reserved for selected patients, including those with prohibitive surgical risk, inoperability, or a role for temporary bridging before later repair.
Management should involve a multidisciplinary team throughout stabilisation, definitive treatment, and consideration of palliative care.
Prognosis and follow-up
Prognosis is poor for all three complications and is particularly adverse when cardiogenic shock or severe ventricular dysfunction is present.
Reported mortality includes:
VSR: approximately 40%–75% overall; mortality exceeds 80% when cardiogenic shock is present.
Free-wall rupture: mortality may reach 75%–90%; even after surgery, hospital mortality may exceed 35%.
Mechanical complications overall: in-hospital mortality of approximately 42.4% in STEMI and 18% in NSTEMI in the cited epidemiological analysis.
For VSR, outcome depends partly on:
Defect size.
The extent of ventricular impairment.
Right- and left-ventricular function.
The location of the defect.
Presence and duration of cardiogenic shock.
Timing of repair.
Early surgery, a short period of shock, and mild right- and left-ventricular impairment are associated with better surgical survival.
After repair, follow-up should assess for persistent or recurrent haemodynamic consequences and residual structural abnormalities. Specific long-term follow-up intervals for infarct-related VSR, free-wall rupture, or papillary muscle rupture are not defined in the source material. Ongoing echocardiographic surveillance is clinically relevant when residual shunting, ventricular dysfunction, pulmonary pressure elevation, or valvular abnormalities persist, although the source material’s detailed interval recommendations relate primarily to congenital or residual VSD rather than post-infarction repair.
